Post-transplant cyclophosphamide for GVHD prophylaxis compared to ATG-based prophylaxis in unrelated donor transplantation

Autor: Bailén R, Kwon M, Pascual-Cascón MJ, Ferrà C, Sanz J, Gallardo-Morillo A, García-Sola A, Torrent A, Jiménez-Lorenzo MJ, Piñana JL, Montoro J, Oarbeascoa G, Dorado N, Gómez-Centurión I, Muñoz C, Martínez-Laperche C, Anguita J, Buño I, Díez-Martín JL

Publikováno v: ANNALS OF HEMATOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

Post-transplant cyclophosphamide (PTCY) effectively prevents graft-versus-host disease after unmanipulated HLA-haploidentical HSCT. The use of PTCY in the unrelated donor HSCT setting is less explored. We conducted a retrospective study of 132 consec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::9385cade62cfc22cf3ff9bb6c027c2b9
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=13061

Cardiac events occurring after allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide. Study conducted on behalf of the GETH-TC.

Autor: Salas MQ; Hospital Clínic de Barcelona, Barcelona, Spain. queralt.salas87@outlook.es., Cascos E; Hospital Clínic de Barcelona, Barcelona, Spain., López-García A; Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Pérez-López E; Complejo Asistencial Universitario de Salamanca/IBSAL, Salamanca, Spain., Baile-González M; Complejo Asistencial Universitario de Salamanca/IBSAL, Salamanca, Spain., López-Corral L; Complejo Asistencial Universitario de Salamanca/IBSAL, Salamanca, Spain., Pascual Cascón MJ; Hospital Regional Universitario de Málaga, Málaga, Spain., Luque M; Hospital Regional Universitario de Málaga, Málaga, Spain., Esquirol A; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Heras Fernando I; Hospital General Universitario Morales Meseguer, Murcia, Spain., Oiartzabal Ormtegi I; Hospital Universitario Donostia, Donostia, Spain., Sáez Marín AJ; Hospital Universitario 12 de Octubre, Madrid, Spain., Peña-Muñóz F; Institut Català d'Oncologia - Hospital Duran i Reynals, Barcelona, Spain., Fernández-Luis S; Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain., Domínguez-García JJ; Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain., Villar Fernández S; Clínica Universidad de Navarra, Pamplona, Spain., Fernández de Sanmamed Girón M; Hospital Universitario de Gran Canaria Doctor Negrín, Gran Canaria, Las Palmas, Spain., González Pinedo L; Hospital Universitario de Gran Canaria Doctor Negrín, Gran Canaria, Las Palmas, Spain., González-Rodríguez AP; Hospital Universitario Central de Asturias, Oviedo, Spain., Torrado T; Hospital Universitario de A Coruña, A Coruña, Spain., García L; Hospital Universitario Son Espases, Palma de Mallorca, Spain., Filaferro S; Grupo Español de Trasplante de Progenitores Hematopoyéticos y Terapia Celular, Madrid, Spain., Cedillo Á; Grupo Español de Trasplante de Progenitores Hematopoyéticos y Terapia Celular, Madrid, Spain., Basalobre P; Grupo Español de Trasplante de Progenitores Hematopoyéticos y Terapia Celular, Madrid, Spain., Ortí G; Grupo Español de Trasplante de Progenitores Hematopoyéticos y Terapia Celular, Madrid, Spain.; Hospital Universitari Vall d'Hebron, Barcelona, Spain., Jurado Chacón M; Grupo Español de Trasplante de Progenitores Hematopoyéticos y Terapia Celular, Madrid, Spain.; Hospital Universitario Virgen de las Nieves de Granada, Granada, Spain.

Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2024 Dec; Vol. 59 (12), pp. 1694-1703. Date of Electronic Publication: 2024 Sep 14.

Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy.

Autor: Bailén R; Department of Hematology and Hemotherapy, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Translational Oncology Section, Gregorio Marañón Health Research Institute, Madrid, Spain., Alenda R; Department of Histocompatibility, Centro de Transfusión de la Comunidad de Madrid, Madrid, Spain., Herruzo-Delgado B; Department of Hematology and Hemotherapy, Hospital Universitario Regional de Málaga, Málaga, Spain., Acosta-Fleitas C; Department of Hematology and Hemotherapy, Hospital Universitario Doctor Negrín, Gran Canaria, Spain., Vallés A; Department of Hematology and Hemotherapy, Hospital Universitario Ramón y Cajal, Madrid, Spain., Esquirol A; Hematology Department, Hospital de la Santa Creu i Sant Pau, Sant Pau Health Research Institute and Jose Carreras Leukemia Research Institutes, Universitat Autonoma of Barcelona, Barcelona, Spain., Fonseca M; Department of Hematology and Hemotherapy, Hospital Clínico Universitario de Salamanca, Salamanca, Spain., Solán L; Department of Hematology and Hemotherapy, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Sánchez-Vadillo I; Department of Hematology and Hemotherapy, Hospital Universitario La Paz, Madrid, Spain., Bautista G; Department of Hematology and Hemotherapy, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., Bento L; Department of Hematology and Hemotherapy, Hospital Universitario Son Espases, Palma de Mallorca, Spain., López-Godino O; Department of Hematology and Hemotherapy, Hospital Universitario Morales Meseguer, Murcia, Spain., Pérez-Martínez A; Department of Hematology and Hemotherapy, Hospital Clínico Universitario de Valencia, Valencia, Spain., Torrent A; Department of Hematology and Hemotherapy, Hospital Germans Trias i Pujol, Barcelona, Spain., Zanabili J; Department of Hematology and Hemotherapy, Hospital Universitario Central de Asturias, Asturias, Spain., Calbacho M; Department of Hematology and Hemotherapy, Hospital Universitario 12 de Octubre, Madrid, Spain., Moreno MÁ; Department of Histocompatibility, Centro de Transfusión de la Comunidad de Madrid, Madrid, Spain., Pascual-Cascón MJ; Department of Hematology and Hemotherapy, Hospital Universitario Regional de Málaga, Málaga, Spain., Guerra-Domínguez L; Department of Hematology and Hemotherapy, Hospital Universitario Doctor Negrín, Gran Canaria, Spain., Chinea A; Department of Hematology and Hemotherapy, Hospital Universitario Ramón y Cajal, Madrid, Spain., García-Cadenas I; Hematology Department, Hospital de la Santa Creu i Sant Pau, Sant Pau Health Research Institute and Jose Carreras Leukemia Research Institutes, Universitat Autonoma of Barcelona, Barcelona, Spain., López-Corral L; Department of Hematology and Hemotherapy, Hospital Clínico Universitario de Salamanca, Salamanca, Spain., Boix-Giner F; Department of Hematology and Hemotherapy, Hospital Clínico Universitario de Salamanca, Salamanca, Spain.; CIBERONC and Centro de Investigación del Cáncer-Instituto de Biología Molecular y Celular del Cáncer (Universidad de Salamanca - CSIC), Salamanca, Spain., López Lorenzo JL; Department of Hematology and Hemotherapy, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Humala K; Department of Hematology and Hemotherapy, Hospital Universitario La Paz, Madrid, Spain., Duarte R; Department of Hematology and Hemotherapy, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., Sampol A; Department of Hematology and Hemotherapy, Hospital Universitario Son Espases, Palma de Mallorca, Spain., Heras I; Department of Hematology and Hemotherapy, Hospital Universitario Morales Meseguer, Murcia, Spain., Vicario JL; Department of Histocompatibility, Centro de Transfusión de la Comunidad de Madrid, Madrid, Spain., Balas A; Department of Histocompatibility, Centro de Transfusión de la Comunidad de Madrid, Madrid, Spain., Oarbeascoa G; Department of Hematology and Hemotherapy, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Translational Oncology Section, Gregorio Marañón Health Research Institute, Madrid, Spain., Fernández-Caldas P; Department of Hematology and Hemotherapy, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Anguita J; Department of Hematology and Hemotherapy, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Translational Oncology Section, Gregorio Marañón Health Research Institute, Madrid, Spain.; Department of Medicine, Universidad Complutense de Madrid, Madrid, Spain., Kwon M; Department of Hematology and Hemotherapy, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Translational Oncology Section, Gregorio Marañón Health Research Institute, Madrid, Spain.; Department of Medicine, Universidad Complutense de Madrid, Madrid, Spain.

Publikováno v: Frontiers in immunology [Front Immunol] 2023 May 26; Vol. 14, pp. 1165759. Date of Electronic Publication: 2023 May 26 (Print Publication: 2023).

Hospital and outpatient models for Hematopoietic Stem Cell Transplantation: A systematic review of comparative studies for health outcomes, experience of care and costs.

Autor: González MJ; Deusto Business School Health, University of Deusto, Bilbao, Spain., Urizar E; Deusto Business School Health, University of Deusto, Bilbao, Spain., Urtaran-Laresgoiti M; Deusto Business School Health, University of Deusto, Bilbao, Spain., Nuño-Solinís R; Deusto Business School Health, University of Deusto, Bilbao, Spain., Lázaro-Pérez E; Faculty of Health Sciences, Valencian International University, Valencia, Spain., Vázquez L; Hematology Service, Hospital Clínico Universitario de Salamanca, Salamanca, Spain., Pascual-Cascón MJ; Hematology Department, BMT Unit. Hospital Regional of Málaga, Málaga, Spain., Solano C; Department of Medicine, Hematology Service, Hospital Clínico Universitario-INCLIVA, School of Medicine, University of Valencia, Valencia, Spain., Kwon M; Department of Hematology, Hospital G. U. Gregorio Marañón, Institute of Health Research Gregorio Marañón, Madrid, Spain., Gallego C; Hematology Department, At-home and Stem Cell Transplantation Unit, Institute of Hematology and Oncology, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain., Fernández-Avilés F; Hematology Department, At-home and Stem Cell Transplantation Unit, Institute of Hematology and Oncology, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.

Publikováno v: PloS one [PLoS One] 2021 Aug 12; Vol. 16 (8), pp. e0254135. Date of Electronic Publication: 2021 Aug 12 (Print Publication: 2021).

Ocular surface characterization after allogeneic stem cell transplantation: A prospective study in a referral center.

Autor: Alba-Linero C; Ophthalmology Department, Hospital Regional of Malaga, Malaga, Spain., Rodriguez Calvo de Mora M; Ophthalmology Department, Hospital Regional of Malaga, Malaga, Spain., Lavado Valenzuela R; Instituto de Investigación Biomédica de Málaga; Laboratorio de Biologia Molecular del Cáncer, Malaga, Spain., Pascual Cascón MJ; Department of Hematology, Hospital Regional of Malaga, Malaga, Spain., Martín Cerezo AR; Department of Hematology, Hospital Regional of Malaga, Malaga, Spain., Álvarez Pérez M; Instituto de Investigación Biomédica de Málaga; Laboratorio de Biologia Molecular del Cáncer; Department of Pathology, School of Medicine, University of Malaga, Malaga, Spain., Recio LV; Department of Pathology, School of Medicine, University of Malaga, Malaga, Spain., Jerez Aragonés JM; Department of Informatics, School of Engineering, University of Malaga, Malaga, Spain., García Campos JM; Department of Ophthalmology, Hospital Clínico Universitario of Malaga, Malaga, Spain.

Publikováno v: Indian journal of ophthalmology [Indian J Ophthalmol] 2020 Aug; Vol. 68 (8), pp. 1556-1562.